Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
BX
|
Vikrant Sawhney
Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct | 85,689 Added 9.81% |
-
|
Apr 01
2025 |
|
SQ
|
Roelof Botha
Director |
BUY
Grant, award, or other acquisition
|
Direct | 253 Added 0.83% |
-
|
Apr 01
2025 |
|
KNSA
|
Sanj K Patel
CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 5,321 Reduced 5.49% |
$115,838
$21.77 p/Share
|
Apr 01
2025 |
|
KNSA
|
Sanj K Patel
CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 12,719 Added 11.61% |
-
|
Apr 01
2025 |
|
BRP
|
Chris Thomas Sullivan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 624 Added 0.77% |
-
|
Apr 01
2025 |
|
BRP
|
Myron K Williams
Director |
BUY
Grant, award, or other acquisition
|
Direct | 624 Added 6.19% |
-
|
Apr 01
2025 |
|
SQ
|
Amy Brooks
Director |
BUY
Grant, award, or other acquisition
|
Direct | 195 Added 0.9% |
-
|
Apr 01
2025 |
|
KNSA
|
Eben Tessari
CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 1,034 Reduced 1.27% |
$22,510
$21.77 p/Share
|
Apr 01
2025 |
|
KNSA
|
Eben Tessari
CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 3,519 Added 4.14% |
-
|
Apr 01
2025 |
|
LHX
|
Joanna Geraghty
Director |
BUY
Grant, award, or other acquisition
|
Direct | 178 Added 5.03% |
$37,335
$209.75 p/Share
|
Apr 01
2025 |
|
MAA
|
Robert J. Del Priore
EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 4,119 Added 6.75% |
-
|
Apr 01
2025 |
|
MAA
|
Robert J. Del Priore
EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 849 Reduced 1.58% |
$142,190
$167.48 p/Share
|
Apr 01
2025 |
|
SQ
|
Shawn Corey Carter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 184 Added 0.77% |
-
|
Apr 01
2025 |
|
KNSA
|
Mark Ragosa
CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 1,617 Reduced 6.05% |
$35,202
$21.77 p/Share
|
Apr 01
2025 |
|
KNSA
|
Mark Ragosa
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 3,342 Added 11.12% |
-
|
Apr 01
2025 |
|
DLTR
|
Michael J Kindy
Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,291 Added 24.41% |
-
|
Apr 01
2025 |
|
DLTR
|
Michael J Kindy
Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 311 Reduced 1.57% |
$23,430
$75.34 p/Share
|
Apr 01
2025 |
|
IMVT
|
Christopher Van Tuyl
Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 50,787 Added 24.01% |
-
|
Apr 01
2025 |
|
MDRX
|
Thomas Langan
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,481 Reduced 0.75% |
$10,544
$4.25 p/Share
|
Apr 01
2025 |
|
RNA
|
Kathleen P. Gallagher
Chief Program Officer |
SELL
Open market or private sale
|
Direct | 5,875 Reduced 10.41% |
$163,501
$27.83 p/Share
|
Apr 01
2025 |
|
RNA
|
Kathleen P. Gallagher
Chief Program Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 5,875 Added 10.35% |
$92,120
$15.68 p/Share
|
Apr 01
2025 |
|
MAA
|
Adrian Hill
EVP, Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,624 Added 8.91% |
-
|
Apr 01
2025 |
|
MAA
|
Adrian Hill
EVP, Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 702 Reduced 1.62% |
$117,570
$167.48 p/Share
|
Apr 01
2025 |
|
BRP
|
Jay A Cohen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 624 Added 4.38% |
-
|
Apr 01
2025 |
|
BRP
|
Joseph John Kadow
Director |
BUY
Grant, award, or other acquisition
|
Direct | 624 Added 4.1% |
-
|
Apr 01
2025 |
|
PARA
|
Shari Redstone
Director |
BUY
Grant, award, or other acquisition
|
Direct | 765 Added 0.13% |
-
|
Apr 01
2025 |
|
JOBY
|
Didier Papadopoulos
President of Aircraft OEM |
BUY
Exercise of conversion of derivative security
|
Direct | 30,018 Added 24.04% |
-
|
Apr 01
2025 |
|
BRP
|
Barbara Ruth Matas
Director |
BUY
Grant, award, or other acquisition
|
Direct | 624 Added 4.1% |
-
|
Apr 01
2025 |
|
JOBY
|
Bonny W Simi
President of Operations |
BUY
Exercise of conversion of derivative security
|
Direct | 16,081 Added 6.82% |
-
|
Apr 01
2025 |
|
JOBY
|
Sergey Novikov
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,392 Added 7.97% |
-
|
Apr 01
2025 |
|
TRIP
|
Matt Goldberg
CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct | 7,793 Reduced 5.89% |
$110,426
$14.17 p/Share
|
Apr 01
2025 |
|
TRIP
|
Matt Goldberg
CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct | 16,116 Added 10.86% |
$228,363
$14.17 p/Share
|
Apr 01
2025 |
|
JOBY
|
Eric Allison
Chief Product Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 13,055 Added 2.12% |
-
|
Apr 01
2025 |
|
JOBY
|
Gregory Bowles
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 11,453 Added 6.5% |
-
|
Apr 01
2025 |
|
JOBY
|
Joe Ben Bevirt
CEO and Chief Architect |
BUY
Exercise of conversion of derivative security
|
Direct | 62,777 Added 6.81% |
-
|
Apr 01
2025 |
|
JOBY
|
Joe Ben Bevirt
CEO and Chief Architect |
SELL
Open market or private sale
|
Indirect | 250,000 Reduced 0.0% |
$1,472,500
$5.89 p/Share
|
Apr 01
2025 |
|
BRP
|
Sathish Muthukrishnan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 624 Added 10.59% |
-
|
Apr 01
2025 |
|
JOBY
|
Kate De Hoff
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 26,810 Added 10.48% |
-
|
Apr 01
2025 |
|
INCY
|
Paula J Swain
EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct | 22,141 Added 17.1% |
-
|
Apr 01
2025 |
|
SIG
|
Joan M Hilson
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 10,878 Reduced 5.64% |
$645,935
$59.38 p/Share
|
Apr 01
2025 |
|
IMVT
|
Michael Geffner
Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 101,574 Added 30.28% |
-
|
Apr 01
2025 |
|
TOST
|
Jonathan Vassil
Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,734 Added 14.35% |
-
|
Apr 01
2025 |
|
INTU
|
Laura A Fennell
EVP, People and Places |
SELL
Payment of exercise price or tax liability
|
Direct | 485 Reduced 2.08% |
$297,785
$613.99 p/Share
|
Apr 01
2025 |
|
INTU
|
Laura A Fennell
EVP, People and Places |
BUY
Exercise of conversion of derivative security
|
Direct | 1,399 Added 5.67% |
-
|
Apr 01
2025 |
|
INCY
|
Steven H Stein
EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 58,165 Added 31.73% |
-
|
Apr 01
2025 |
|
TOST
|
Aman Narang
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 20,494 Added 6.47% |
-
|
Apr 01
2025 |
|
FIGS
|
Hsiao Yueh Jao
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,923 Added 10.08% |
-
|
Apr 01
2025 |
|
INCY
|
Christiana Stamoulis
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 37,568 Added 22.54% |
-
|
Apr 01
2025 |
|
TOST
|
Stephen Fredette
President |
BUY
Exercise of conversion of derivative security
|
Direct | 12,914 Added 0.9% |
-
|
Apr 01
2025 |
|
DLR
|
Christine Beseda Kornegay
CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 35 Reduced 1.22% |
$5,111
$146.05 p/Share
|
Apr 01
2025 |